Pancreas

HIFU TREATMENT CRITERIA FOR PATIENTS WITH PANCREATIC CANCER

INDICATIONS FOR HIFU - ABLATION

• Histologically verified pancreatic cancer
• The patient cannot withstand a radical surgery
• Unresectable carcinoma
• Expected survival for more than 3 months
• The tumor is clearly visible with ultrasound
• The patient has no clinical manifestations of obstructive jaundice
• Possibility to provide enough and safe  acoustic approach to the  tumor
• Patients in stage 4 with a strong pain syndrome of morphine derivatives
• Patients have applied  at least 3 courses of chemotherapy before  the HIFU - ablation
• Signed informed consent  for the  ablation

CONTRAINDICATIONS FOR HIFU - ABLATION:

• Contraindications for general anesthesia
• After surgery for  jaundice, the tumor is not visible with ultrasound due to large postoperative scars, adhesions etc.
• The presence of metal particles (clips) after surgery / pankreatoektomiya /
• Obstructive jaundice
• Thrombosis of the inferior vena cava and / or portal vein Completely broken upper mesenteric vessels
• Massive calcification of the vessels
• Patients after radiotherapy with  a dose over 45 GY.

HAYFU treatment in patients with advanced pancreatic cancer

indication:

• Histologically or cytologically proven pancreatic cancer
• pancreatic cancer in which operation is not possible
• A patient with a strong pain syndrome of morphine derivatives
• A patient with a strong pain syndrome of morphine derivatives
• 3 courses of chemotherapy before ablation
• Patient preserved structural condition
• Signed informed consent for ablation
• A patient who can not withstand radical surgery
• Patient not clinically manifested obstructive jaundice
• A patient who has no leukocytosis

absolute contraindications:

• After operations on the occasion of jaundice tumor is not visible by ultrasound
• Great postoperative scarring limiting ablation, multiple adhesions, etc..
• obstructive jaundice
• Completely disabled or under 30% flow in the upper mesenteric vessels, truncus tseliakus, vein porter, etc.
• Calcification of vessels
• Patient after radiation therapy at a dose of 45 GY
• data from computed tomography for thrombosis and arterial venous vessels in
• Availability of leukocytosis
• Poor general condition
• Lack of histological and cytological evidence of pancreatic cancer

elative contraindications:

• Relative contraindications
• Plastic bench at the common bile duct.
• Infiltration of a hollow organ abdominal tumor
• Obstructive jaundice
• Lack of consultation with experienced hepatobiliary surgeon

These patients go through a committee of experienced professionals Hayfu
for their approval or rejection for conducting extracorporeal ablation
in advanced pancreatic cancer.